| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |